After dropping headline-grabbing phase 3 data for its pancreatic cancer candidate daraxonrasib last week, Revolution Medicines is not resting on its laurels. The Bay Area biotech has spent several ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...

RAS proteins, their regulators and the downstream enzymes that they control are activated in many tumour types by a variety of mechanisms, including oncogenic mutation of RAS genes. They are crucial ...

Sean Ross is a strategic adviser at 1031x.com, Investopedia contributor, and the founder and manager of Free Lances Ltd. Direct distribution allows manufacturers to control all aspects of distribution ...

A main benefit of 401(k) plans and individual retirement accounts is the ability to delay taxes on contributions and investment gains. However, you can’t avoid the tax man forever. “Once you reach a ...

SPX FLOW, a maker of highly engineered equipment and process technologies for the industrial, health and nutrition markets, has been purchased by ITT, a diversified manufacturer of highly engineered ...

Organizations across the world are racing to modernize supply chains that were designed for an era defined by manual processes, fragmented tools, and limited visibility. Moving from these traditional ...

Jeffrey, we're delighted to hear that Matt made your car-buying experience smooth at Flow Honda in Winston-Salem. We look forward to assisting you with your next purchase!

Details about an Expanded Access Program (EAP) for daraxonrasib are now available. The EAP is intended to provide daraxonrasib to eligible adult patients with previously treated metastatic pancreatic ...